REQUEST A DEMO
Total
USD $0.00
Search more companies

Drc Kft. (Hungary)

Main Activities: Outpatient Care Centers
Full name: DRC Gyogyszervizsgalo Kozpont Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

DRC - Drug Research Center is a private company that specializes in conducting clinical trials for medical devices and pharmaceutical preparations. DRC - Drug Research Center offers Phase I, bioequivalence, phase II, III, and IV tests, as well as cell biological and genotyping services for domestic and foreign sponsors. The company has gained extensive experience in traditional, small molecular, biological, and biosimilar preparations and has its own clinic and research laboratory background.

Headquarters
Szabadsag utca 18.
Budapest; Budapest; Postal Code: 1028

Contact Details: Purchase the Drc Kft. report to view the information.

Website: http://www.drc.hu

Basic Information
Total Employees:
Purchase the Drc Kft. report to view the information.
Outstanding Shares:
Purchase the Drc Kft. report to view the information.
Registered Capital:
Purchase the Drc Kft. report to view the information.
Financial Auditors:
Purchase the Drc Kft. report to view the information.
Incorporation Date:
July 10, 1995
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
KEREKED Ingatlanhasznosito es Vagyonkezelo Kft.
Company Performance
Financial values in the chart are available after Drc Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
9.35%
Total operating revenue
8.51%
Operating profit (EBIT)
31.95%
EBITDA
27.36%
Net Profit (Loss) for the Period
-13.48%
Total assets
30.96%
Total equity
24.5%
Operating Profit Margin (ROS)
4.4%
Net Profit Margin
-4.59%
Return on Equity (ROE)
-8.64%
Quick Ratio
-3.9%
Cash Ratio
-3.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?